Cancer coagulopathy is thought to be partially due to the up-regulation of tissue factor (TF), a 47-kd glycoprotein expressed on the cell surface, which is the principal physiologic initiator of the extrinsic coagulation pathway as factor VII/VIIa receptor. Here, TF is linked to cancer.